Skip to main contentSkip to navigation
Peptide Atlas
Back to Experts

Dr. Sarah Chen

Researcher

Peptide Research Scientist

National Institute of Health

Ph.D.Peptide Biochemistry

Dr. Chen has over 15 years of experience researching therapeutic peptides. Her work focuses on peptide stability, delivery systems, and clinical applications.

Specialization

Peptide StabilityDelivery SystemsClinical Research

The Future of Peptide Therapeutics: A Research Perspective

An in-depth conversation with Dr. Sarah Chen about the current state and future directions of peptide research.

January 30, 2024

1What makes peptides particularly interesting as therapeutic agents?

Peptides offer several advantages over traditional small molecules. They're highly specific, often with fewer off-target effects. They can be designed to target specific receptors or pathways. However, challenges remain around stability, delivery, and cost of production.

2What are the biggest challenges in peptide research today?

Delivery remains a major challenge - many peptides are degraded by enzymes in the gastrointestinal tract, so they often need alternative delivery routes. Stability is another concern, as peptides can be sensitive to temperature and pH. Additionally, the cost of production can be significant for complex peptides.

3What excites you most about the future of peptide therapeutics?

I'm particularly excited about the potential for personalized peptide therapeutics and the development of more stable, orally bioavailable peptides. Advances in delivery systems and formulation techniques are opening new possibilities.

researchfuturetherapeutics